Our data display that CK18 is consistently expressed in several epithelial cancers, Primarily adenocarcinomas. Both loss of CK18 expression in cancers derived from CK18 constructive precursor cells and neo-expression in malignancies derived from CK18 optimistic precursors are usually here linked to unfavorable tumor phenotype and disease result. o